Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-025 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0075 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
filingDate |
2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2011-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2011516091-A |
titleOfInvention |
Novel therapeutic tools and methods for the treatment of blindness |
abstract |
The present invention relates to the treatment or alleviation of blindness comprising a nucleic acid sequence encoding a hyperpolarized light-gated ion channel or pump gene derived from archaebacteria or a photoactivated fragment of the gene, or a nucleotide sequence complementary to the nucleic acid sequence. The use of isolated nucleic acid molecules for The light-gated ion channel or pump gene can be a halorhodopsin gene. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7048585-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7042741-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018531004-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018506982-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017501834-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019500863-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019532636-A |
priorityDate |
2008-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |